Global Custom Market Research Reports Provider Company

phone

Antaros Medical AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 19
  • Category: Pharmaceuticals
  • Country: Sweden
Summary

Antaros Medical AB (Antaros Medical) is a drug development technology company which offers innovative MRI and PET imaging techniques for decision making in clinical drug development. The companys services include small- to medium-sized studies, decision-making in Phase 1b and Phase 2 trials, expert support for product differentiation in life cycle management, pre-clinical services, regulatory approval, and life cycle management services. Antaros Medicals imaging endpoints includes B-cell mass and function, insulin resistance, and body composition, atherosclerosis measurement, and assessment of coronary atherosclerosis. The companys targeted therapeutic areas include cardio-metabolic, respiratory, inflammatory, and neuroscience diseases. It operates in Uppsala and Gothenburg, Sweden. Antaros Medical is headquartered in Uppsala, Sweden.

Antaros Medical AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antaros Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antaros Medical AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Athera Biotech Raises USD7.2 Million in Venture Financing 10
Emeriti Pharma Raises USD0.3 Million in Venture Financing 12
Athera Biotechnologies Raises USD2.8 Million in Venture Financing 13
Acquisition 14
Ostersjostiftelsen Consortium to Acquire Stake in Athera Biotechnologies from Karolinska Development 14
Antaros Medical AB - Key Competitors 16
Antaros Medical AB - Key Employees 17
Antaros Medical AB - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
Antaros Medical AB, Pharmaceuticals & Healthcare, Key Facts 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antaros Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antaros Medical AB, Deals By Therapy Area, 2012 to YTD 2018 8
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Athera Biotech Raises USD7.2 Million in Venture Financing 10
Emeriti Pharma Raises USD0.3 Million in Venture Financing 12
Athera Biotechnologies Raises USD2.8 Million in Venture Financing 13
Ostersjostiftelsen Consortium to Acquire Stake in Athera Biotechnologies from Karolinska Development 14
Antaros Medical AB, Key Competitors 16
Antaros Medical AB, Key Employees 17
Antaros Medical AB, Other Locations 18

List Of Figures

List of Figures
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antaros Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from

View Report

Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services. Pharmstandards product portfolio

View Report

Orexigen Therapeutics Inc (Orexigen) is a biopharmaceutical company which develops and commercializes indications for the treatment of obesity. Its lead product, Contrave (naltrexone HCl / bupropion HCl prolonged release) is

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports